Income Statement
Quarterly Data
The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Based on: 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).
Income statement item | Description | The company |
---|---|---|
Revenue | Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. | Biogen Inc. revenue increased from Q1 2022 to Q2 2022 but then decreased significantly from Q2 2022 to Q3 2022. |
Income from operations | The net result for the period of deducting operating expenses from operating revenues. | Biogen Inc. income from operations increased from Q1 2022 to Q2 2022 and from Q2 2022 to Q3 2022. |
Income before income tax (expense) benefit | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Biogen Inc. income before income tax (expense) benefit increased from Q1 2022 to Q2 2022 and from Q2 2022 to Q3 2022. |
Net income attributable to Biogen Inc. | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Biogen Inc. net income attributable to Biogen Inc. increased from Q1 2022 to Q2 2022 and from Q2 2022 to Q3 2022. |